医学
基质金属蛋白酶
伤口愈合
细胞外基质
下肢静脉性溃疡
伤口护理
慢性伤口
辅助治疗
随机对照试验
临床试验
重症监护医学
外科
内科学
生物
细胞生物学
作者
Penelope Kallis,Adam Friedman
出处
期刊:PubMed
日期:2018-04-01
卷期号:17 (4): 403-408
被引量:16
摘要
Chronic wounds, such as pressure ulcers, diabetic foot ulcers, and venous leg ulcers, are associated with high costs, poor quality of life, and significant morbidity and mortality. A chronic wound develops when progression through the normal phases of wound healing goes awry, creating a hostile environment with elevated levels of pro-inflammatory cytokines, increased matrix metalloproteinases (MMPs), destruction of extracellular matrix (ECM) components, and diminished activity of growth factors and other soluble mediators. The advent of advanced wound care therapies allows for a targeted approach to the treatment of nonhealing wounds by addressing specific molecular defects in healing. Collagen is an essential building block of the skin that when utilized as an adjunctive wound therapy stimulates and recruits immune cells and fibroblasts and martyrs itself for degradation by MMPs, thereby preserving native ECM structure and promoting healing. Particulate or powdered collagen is processed to minimize covalent cross-linking and is purported to exert its biologic activity immediately upon application. This article critically reviews the current evidence for collagen powder as an adjunctive therapy for chronic wounds and presents indications, limitations, and principles of use. In general, there is a need for high quality studies and randomized control trials to support its use in clinical practice. J Drugs Dermatol. 2018;17(4):403-408. .
科研通智能强力驱动
Strongly Powered by AbleSci AI